Hanley is Chief Technical Operations Officer at Nuvation Bio, Inc. In his past career Dr. Hanley held the position of VP-Pharmaceutical Sciences & Technical Operations at Radius Health, Inc., Senior VP & Head-Global Pharmaceutical Development at BioXcel Therapeutics, Inc. and Senior Director-Global Pharmaceutical Development at The Medicines Co. He received an undergraduate degree from Virginia Commonwealth University and a doctorate from the University of Utah.
Known holdings in public companies
|Number of shares
|6,000 ( 0.00% )
|9 720 $
David C. Hanley active positions
Former positions of David C. Hanley
Training of David C. Hanley
|University of Utah
|Virginia Commonwealth University
1st degree connections
1st degree companies
Members of the board
|BIOXCEL THERAPEUTICS, INC.
The Medicines Co.
Pharmaceuticals: MajorHealth Technology
The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.
Radius Health, Inc.
Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.
|Nuvation Bio, Inc.